Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (101-110 of 894) with videos related to

Pageof 90
Sort By:
Nature Reviews. Nephrology|October 27, 2009
Transplantation: time to rethink immunosuppression by mTOR inhibitors?Marcus D Säemann, Giuseppe Remuzzi
Journal of Hypertension|August 19, 2003
Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?Gozewijn D Laverman, Giuseppe Remuzzi
BMC Nephrology|July 13, 2016
Diets for patients with chronic kidney disease, should we reconsider?William E Mitch, Giuseppe Remuzzi
Lancet (London, England)|May 8, 2007
Target haemoglobin concentrations in chronic kidney diseaseJulie R Ingelfinger, Giuseppe Remuzzi
Lancet (London, England)|February 24, 2024
The Italian health-care crisis-only a matter of funding?Livio Garattini, Alessandro Nobili, Giuseppe Remuzzi
Kidney International|August 13, 2010
Sirolimus for calcineurin inhibitors in organ transplantation: contraPaolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
The New England Journal of Medicine|March 23, 2012
Eculizumab in a patient with dense-deposit diseaseErica Daina, Marina Noris, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 25, 2003
Transplant renal artery stenosisSimona Bruno, Giuseppe Remuzzi, Piero Ruggenenti
Current Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe Remuzzi
Journal of Hepatology|March 28, 2006
Let's assume that hepatitis C reduces the cardiovascular risk in dialysis patients: are there practical implications?Dario Cattaneo, Norberto Perico, Giuseppe Remuzzi
Pageof 90

Showing results (101-110 of 894) with videos related to

Sort By:
Pageof 90
Nature Reviews. Nephrology|October 27, 2009
Transplantation: time to rethink immunosuppression by mTOR inhibitors?Marcus D Säemann, Giuseppe Remuzzi
Journal of Hypertension|August 19, 2003
Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?Gozewijn D Laverman, Giuseppe Remuzzi
BMC Nephrology|July 13, 2016
Diets for patients with chronic kidney disease, should we reconsider?William E Mitch, Giuseppe Remuzzi
Lancet (London, England)|May 8, 2007
Target haemoglobin concentrations in chronic kidney diseaseJulie R Ingelfinger, Giuseppe Remuzzi
Lancet (London, England)|February 24, 2024
The Italian health-care crisis-only a matter of funding?Livio Garattini, Alessandro Nobili, Giuseppe Remuzzi
Kidney International|August 13, 2010
Sirolimus for calcineurin inhibitors in organ transplantation: contraPaolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
The New England Journal of Medicine|March 23, 2012
Eculizumab in a patient with dense-deposit diseaseErica Daina, Marina Noris, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 25, 2003
Transplant renal artery stenosisSimona Bruno, Giuseppe Remuzzi, Piero Ruggenenti
Current Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe Remuzzi
Journal of Hepatology|March 28, 2006
Let's assume that hepatitis C reduces the cardiovascular risk in dialysis patients: are there practical implications?Dario Cattaneo, Norberto Perico, Giuseppe Remuzzi
Pageof 90